Mode
Text Size
Log in / Sign up

Small-donor single-kidney transplants show lower 1-year graft survival and higher acute rejection ratesSmall donor kidneys show promise for children needing transplants

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that small-donor single-kidney transplants are associated with lower 1-year graft survival and higher acute rejection.

This meta-analysis and retrospective cohort study evaluate the clinical outcomes of single-kidney transplantation from small pediatric donors (weight ≤ 15 kg or age ≤ 3 years) compared to large-donor recipients in a pediatric population. The analysis includes a cohort of 77 patients and a meta-analysis of 527 patients.

In the cohort study, 1-year graft survival was significantly lower in the small-donor group (73.1%) compared to the large-donor group (100%; P < 0.001). Additionally, the small-donor group experienced a higher rate of acute rejection (19.2% vs 2.0%; P = 0.026). Other outcomes, including thrombosis, delayed graft function (DGF), patient survival, and eGFR at 1 year, were comparable between groups. Operative time in the small-donor cohort decreased from 187.6 to 146.3 minutes following a specific milestone.

The meta-analysis reported pooled rates of 98% for 1-year patient survival, 91% for graft survival, 5% for thrombosis, 13% for DGF, and 10% for acute rejection. The authors note that while early graft loss risk may decline after a learning phase, long-term efficacy requires prospective validation. These findings suggest that while short-term outcomes and organ utilization are acceptable, specific risks regarding graft survival and acute rejection are associated with small-donor kidneys.

When a child needs a kidney transplant but only one kidney is available, doctors must weigh the risks of using a smaller donor organ. This study looked at children who received a single kidney from small pediatric donors, such as those under 3 years old or weighing less than 15 kilograms. The goal was to see how these kidneys performed compared to those from larger donors.

In a group of 77 children, the data showed that while the risk of early graft loss was higher in the small-donor group, the risk dropped significantly as the surgical team gained experience. While the first few cases were more complex, the time spent in surgery decreased over time. Other factors, like the risk of blood clots or the patient's overall survival, were similar between both groups.

A larger analysis of 527 cases showed a 91% graft survival rate and a 98% patient survival rate. While these results are encouraging for organ use, the researchers noted that more long-term studies are needed to confirm how these small kidneys perform over many years.

What this means for you:
Small donor kidneys can be effective for children, with risks decreasing as surgical teams gain experience.

Common questions

Are small donor kidneys safe for children?

Yes, the data shows high survival rates. In a large analysis of 527 cases, patient survival was 98% and graft survival was 91%. While some risks like acute rejection were higher in the small-donor group (19.2% vs 2.0%), the overall outcomes remain promising for these patients.

How does the risk change as surgeons get more experience?

The risk of early graft loss decreases as the surgical team learns the procedure. In the study of 77 children, the time required for surgery dropped from 187.6 to 146.3 minutes after the 16th case, showing that the process becomes more efficient and manageable over time.

What are the risks of using a small donor kidney?

One specific risk is a higher rate of acute rejection, which is a short-term immune response against the new organ. In the small-donor group, this happened in 19.2% of cases compared to 2.0% in the larger donor group. Other factors like blood clots and patient survival were similar between both groups.

Study Details

Study typeMeta analysis
Sample sizen = 527
EvidenceLevel 1
Follow-up36.0 mo
PublishedSep 2026
View Original Abstract ↓
OBJECTIVE: To evaluate clinical outcomes of single-kidney transplantation from small pediatric donors (weight ≤ 15 kg or age ≤ 3 years). METHODS: This retrospective cohort study included 77 children transplanted at our center (Oct 2022-May 2026): 26 small-donor vs. 51 large-donor recipients. CUSUM learning curve analysis and meta-analysis of seven studies (527 patients) were performed. RESULTS: In the cohort, small-donor group had lower 1-year graft survival (73.1% vs. 100%, P < 0.001) and higher acute rejection (19.2% vs. 2.0%, P = 0.026), while thrombosis, DGF, and patient survival were similar. EGFR at 1 year was comparable between groups. CUSUM showed an inflection at Case 16 in the small-donor group, with operative time decreasing from 187.6 to 146.3 min. Meta-analysis yielded 1-year patient survival of 98%, graft survival 91%, and pooled thrombosis, DGF, and acute rejection rates of 5%, 13%, and 10%, respectively. CONCLUSIONS: Early graft loss risk in small-donor single-kidney transplantation declines after the learning phase, with acceptable short-term outcomes and high organ utilization. This approach appears feasible in experienced centers, though long-term efficacy requires prospective validation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.